What is the Share Price of Panacea Biotec Ltd?

Panacea Biotec Ltd share price is ₹447.50 As on 09 June, 2025|07:35

Home
>
Stocks
>
Panacea Biotec Ltd

Panacea Biotec Ltd Share Price

Q: What is the Market Cap of Panacea Biotec Ltd?

The Market Cap of Panacea Biotec Ltd is ₹2,741 As on 09 June, 2025|07:35

Q: What is PE Ratio of Panacea Biotec Ltd?

The P/E ratio of Panacea Biotec Ltd is 0 As on 09 June, 2025|07:35

Q: What is PB Ratio of Panacea Biotec Ltd?

The PB ratio of Panacea Biotec Ltd is 3.29 As on 09 June, 2025|07:35

₹ 447.50 -23.80 (-5.05%)
Updated on 08-06-2025 8:25 AM

Stock Rating

Pros 2

Cons 8

Panacea Biotec Ltd Price Performance

Day's Low
₹442.6

Day's High
₹475.2

₹ 447.5

52-w low
₹117.35

52-w high
₹581.9

447.5

Day's open
₹471.3
Previous close
₹471.299988
VWAP
₹453.46
Lower price band
₹402.75
Upper price band
₹492.25

Today's Market Action

The last traded share price of Panacea Biotec Ltd was 447.50 down by -5.05% on the NSE. Its last traded stock price on BSE was 450.15 down by -4.43%. The total volume of shares on NSE and BSE combined was 338,454 shares. Its total combined turnover was Rs 15.35 crores.

Panacea Biotec Ltd Medium and Long Term Market Action

Panacea Biotec Ltd hit a 52-week high of 581.9 on 30-04-2025 and a 52-week low of 117.35 on 05-06-2024. The stock price of Panacea Biotec Ltd is down by -11% over the last one month. It is up by 245.56% over the last one year. Don't forget to check the full stock price history in the table below.

Panacea Biotec Ltd Fundamentals

Market Cap (Cr): 2741
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Panacea Biotec Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Panacea Biotec Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Panacea Biotec Ltd

Data not available.

Panacea Biotec Ltd FAQ's

What is Share Price of Panacea Biotec Ltd?

What is the Market Cap of Panacea Biotec Ltd?

What is PE Ratio of Panacea Biotec Ltd?

What is PB Ratio of Panacea Biotec Ltd?

What is the CAGR of Panacea Biotec Ltd?

How to Buy Panacea Biotec Ltd Share?

Can I buy Panacea Biotec Ltd from Samco?

How do I buy Panacea Biotec Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.03. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
Above Average Growth Rate
The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only 0.00% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Negative operating earnings and interest coverage
The company has a negative operating earnings and a negative Interest coverage ratio of -5.00 times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.81. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 157 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(09/06/2025)

Margin of Safety Index: High

37.50%

37.50% People are bullish about Panacea Biotec Ltd

62.50%

62.50 % People are bearish about Panacea Biotec Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %